二氯[（4S，5S）-（+）-4,5-双（二苯基膦甲基）-2,2-二甲基-1,3-二氧戊环] [（S）-（-）-2-（异丙基）甲胺）-1H-苯并咪唑]钌（II）

Dichloro[(4S,5S)-(+)-4,5-bis(diphenylphosphinomethyl)-2,2-dimethyl-1,3-dioxolane][(S)-(-)-2-(i-propyl)methanamine)-1H-benzimidazole]ruthenium(II)

98%

四氟硼酸氯[（R）-2,2''-双（二苯基膦基）-1,1''-联萘基] [2-（二苯基膦基乙乙胺）钌（II）四氟硼酸钌（II）

Chloro[(R)-2,2''-bis(diphenylphosphino)-1,1''-binaphthyl][2-(diphenylphosphino)ethanamine]ruthenium(II) tetrafluoroborate

98%

4-[(4-丁基苯基)乙炔基]-2-氟-异硫氰酸苯酯

4-[2-(4-butylphenyl)ethynyl]-2-fluoro-1-isothiocyanatobenzene

99%

氯（间苯三甲）[（1R，2R）-（-）-2-氨基-1,2-二苯乙基（甲基磺酰胺基）]钌（II）RuCl（间苯三甲）[[R，R）-MsDpen]RuCl(mesitylene)[(R,R)-MsDpen]

Chloro(mesitylene)[(1R,2R)-(-)-2-amino-1,2-diphenylethyl(methylsulfonylamido)]ruthenium(II) RuCl(mesitylene)[(R,R)-MsDpen]

98%

O-叔丁基-L-苏氨酸, 99%

O-tert-Butyl-L-threonine

白桦脂酸, 分析对照品

Betulinic acid

(S)-3-[1-(4-甲氧基苯磺酰基)-(4S,5S)-4,5-二苯基-4,5-二氢-1H-咪唑-2-基]-1,1'-联萘-2,2'-二基磷酸氢盐, ≥96%

(S)-3-[1-(4-Methoxybenzenesulfonyl)-(4S,5S)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl]-1,1'-binaphthalene-2,2'-diyl Hydrogen Phosphate

(S)-3,3'-双(2,3,4,5,6-五氟苯基)-1,1'-联萘酚磷酸酯, ≥99%,99.9%e.e.

(S)-3,3'-Bis(2,3,4,5,6-pentafluorophenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

氯甲酸(-)-薄荷基酯, ≥98%(T)

(-)-Menthyl Chloroformate

(-)-B-氯化二异松香芹硼烷, 60% in Heptane, ca. 1.7 mol/L, MkSeal

(-)-B-Chlorodiisopinocampheylborane

(+)二异松蒎基氯硼烷, 60% in Heptane,ca. 1.7mol/L

(+)-B-Chlorodiisopinocampheylborane

(-)-4,5-双[(2R,5R)-2,5-二甲基膦酰基](1,2-二甲基-1,2-二氢哒嗪-3,6-二酮)(1,5-环辛二烯)铑(I)四氟硼酸盐, ≥98%

(-)-4,5-Bis[(2R,5R)-2,5-dimethylphospholanyl](1,2-dimethyl-1,2-dihydropyridazine-3,6-dione)(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate

(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥99%,99.9%e.e.

(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥99%,99.9%e.e.

(11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥99%,99.9%e.e.

(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥99%,99.9%e.e.

(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11bR)-4-羟基-2,6-双(全氟苯基)二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂环庚三烯4-氧化物, 99%

(11bR)-4-Hydroxy-2,6-bis(perfluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥99%,99.9%e.e.

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(2S)-2-[[[[(1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N,3,3-三甲基-N-(苯基甲基)丁酰胺, ≥99%,99.9%e.e.

(2S)-2-[[[[(1R,2R)-2-Aminocyclohexyl]amino]thioxomethyl]amino]-N,3,3-trimethyl-N-(phenylmethyl)butanamide

(2S)-2-[[[[(1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯基甲基)-N,3,3-三甲基丁酰胺, ≥99%,99.9%e.e.

(2S)-2-[[[[(1R,2R)-2-Aminocyclohexyl]amino]thioxomethyl]amino]-N-(diphenylmethyl)-N,3,3-trimethylbutanamide